ImmunityBio, Inc.
IBRX- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001326110
In the last 90 days, ImmunityBio, Inc. insiders filed 0 open-market purchases and 2 sales; 405 institutions reported holding it in 13F filings for Q2 2026, worth $1.76B in total; no superinvestor holds it.
Q3 2021 vs. Q2 2021
How the institutions holding ImmunityBio, Inc. changed between Q2 2021 and Q3 2021.
All holders in Q3 2021All holders in Q2 2021
| Measure | Q2 2021 | Of which not filed for Q3 2021 | Q3 2021 | Change |
|---|---|---|---|---|
| Holders | 118 | 3 | 121 | +6 |
| Shares | 27.8M | 321.9K | 31.9M | +4.47M (+16.3%) |
| Value | $390.1M | $4.60M | $310.9M | −$74.6M (−19.3%) |
3 institutions that held it in Q2 2021 haven't filed for Q3 2021 yet. Not filing isn't selling, so the changes leave them out.
New holders (20)
Institutions that held ImmunityBio, Inc. at the end of Q3 2021 but not at the end of Q2 2021.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Pictet Asset Management SA | 311,234 | $3.03M | 0.00% |
| Renaissance Technologies LLC | 207,917 | $2.02M | 0.00% |
| Prudential Financial Inc | 104,620 | $1.02M | 0.00% |
| AXA S.A. | 28,800 | $281.0K | 0.00% |
| Virtu Financial LLC | 20,127 | $196.0K | 0.02% |
| Franklin Resources Inc | 19,500 | $190.0K | 0.00% |
| CIBC Asset Management Inc | 15,583 | $152.0K | 0.00% |
| JustInvest LLC | 15,446 | $150.0K | 0.01% |
| Oppenheimer & Co Inc | 14,720 | $143.0K | 0.00% |
| E Fund Management Co., Ltd. | 12,638 | $123.0K | 0.01% |
| Teacher Retirement System of Texas | 12,079 | $118.0K | 0.00% |
| Dimensional Fund Advisors LP | 10,455 | $102.0K | 0.00% |
| FNY Investment Advisers, LLC | 5,000 | $48.0K | 0.02% |
| Captrust Financial Advisors | 1,920 | $19.0K | 0.00% |
| Gleason Group, Inc. | 1,000 | $10.0K | 0.00% |
| SRS Capital Advisors, Inc. | 600 | $6.00K | 0.00% |
| PSI Advisors, LLC | 350 | $3.00K | 0.00% |
| Kowal Investment Group, LLC | 104 | $1.00K | 0.00% |
| Koshinski Asset Management, Inc. | 41 | $399 | 0.00% |
| Ci Investments Inc. | 4 | $0 | 0.00% |
Sold out (14)
Institutions that held ImmunityBio, Inc. at the end of Q2 2021 and filed for Q3 2021 without it.
| Institution | Shares, Q2 2021 | Value, Q2 2021 |
|---|---|---|
| First Trust Advisors LP | 250,096 | $3.57M |
| Engineers Gate Manager LP | 87,745 | $1.25M |
| Two Sigma Investments, LP | 85,579 | $1.22M |
| Twinbeech Capital LP | 83,765 | $1.20M |
| Arrowstreet Capital, Limited Partnership | 65,700 | $938.0K |
| Squarepoint Ops LLC | 62,550 | $893.0K |
| Cambridge Investment Research Advisors, Inc. | 28,568 | $408.0K |
| Illinois Municipal Retirement Fund | 15,973 | $228.0K |
| Jackson, Grant Investment Advisers, Inc. | 5,000 | $71.0K |
| Dark Forest Capital Management LP | 3,692 | $53.0K |
| Point72 Hong Kong Ltd | 310 | $4.00K |
| Sugarloaf Wealth Management, LLC | 200 | $3.00K |
| Tradition Wealth Management, LLC | 200 | $3.00K |
| FMR LLC | 100 | $1.00K |
Not filed for Q3 2021 yet (3)
Institutions that held ImmunityBio, Inc. at the end of Q2 2021 and haven't filed a 13F for Q3 2021. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q2 2021 | Value, Q2 2021 |
|---|---|---|
| Pictet Asset Management Ltd | 302,345 | $4.32M |
| QS Investors, LLC | 19,500 | $279.0K |
| CWM, LLC | 100 | $1.00K |